Bristol-Myers Squibb names new chief commercial officer

pharmafield logo - pharma news

Bristol-Myers Squibb has recruited Murdo Gordon to the newly-created role of executive vice-president and chief commercial officer.

Mr Gordon will assume responsibility for leading the execution of the company’s commercial strategy, leading worldwide market activity in addition to a new global commercialisation team.

Mr Gordon joined the company in 1989, holding positions for 13 years in Canada in sales and marketing, before moving to Bristol-Myers Squibb’s US operations in 2003.

Since then, he has occupied senior commercial leadership positions in cardiovascular, neuroscience and market access, most recently serving as joint leader of its commercial organisation as head of worldwide markets.

Dr Giovanni Caforio, chief executive officer of Bristol-Myers Squibb, said: “Murdo has made significant contributions to our success in immuno-oncology and Eliquis, and I am confident his leadership will help drive continued growth and deliver our medicines to more patients faster.”